Ranbaxy gets Australia nod for antipsychotic drug

Drug major Ranbaxy on Wednesday said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country. Ranbaxy Australia, the wholly......

Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008. This increase is despite......

Sun Pharma challenges J&J's drug patent

Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J)......

Ranbaxy signs Canadian generic deal

Ranbaxy Laboratories, the country's largest pharmaceutical company by sales, on Wednesdayannounced that it had signed a licensing and supply agreement that will make it the first Indian company to......